Society for research on nicotine and tobacco

Author(s): Benowitz, N., Henningfield, J., Newhouse, P., Pomerleau, O., Swan, G.

Journal/Book: Addiction. 1996; 91: PO Box 25, Abingdon, Oxon, England OX14 3UE. Carfax Publ Co. 129-137.

Abstract: The proceedings of the inaugural scientific meeting of the Society for Research on Nicotine and Tobacco (SRNT) are summarized. The primary objective of the meeting was to foster the exchange of information on the effects of nicotine and tobacco use, as well as factors which influence their use, drawing from biological, behavioral and social sciences. Much of this research can be viewed as a tale of ''two'' drugs-nicotine as a Key to an important public health problem, and nicotine as a classical tool of physiological and pharmacological research. A historical overview of research on ''both'' drugs is provided first. Public policy alternatives for reducing the prevalence of tobacco use have been derived in part from basic and clinical research results and are briefly outlined. Evidence for genetic determinants on nicotine use and effects is presented using data from twin studies and from molecular genetic research with humans and animals. Consistent with this research, there is evidence of individual differences in pharmacokinetics and effects of nicotine, which could account for differences in smoking behavior and nicotine dependence. Finally, recent developments in the therapeutic uses of nicotine and novel nicotinic agonists with schizophrenia, Alzheimer's disease, Parkinson's disease, Tourette's syndrome and ulcerative colitis are presented. Overall, the research presented at the meeting demonstrated the vast diversity of areas of study involving nicotine and tobacco, as well as the rich opportunities for cross-communication among researchers from different disciplines.

Note: Editorial KA Perkins, Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, 3811 Ohara St, Pittsburgh, PA 15213 USA

Keyword(s): SMOKING CESSATION; TOLERANCE; HALOPERIDOL

Zurück | Weiter